Dr. Rupesh Patki
About Dr. Rupesh Patki
Dr. Rupesh Patki is a Senior Director of Clinical Trial Management at Prothena Corporation plc, with over 23 years of experience in global clinical operations. He has held various leadership roles in clinical operations at companies such as Revance Therapeutics, Allergan, and Amgen, and specializes in inspection readiness, quality assurance, and process improvements.
Current Role at Prothena
Dr. Rupesh Patki serves as the Senior Director of Clinical Trial Management at Prothena Corporation plc. He has held this position since 2021, contributing to the company's clinical operations in South San Francisco, California. His role involves overseeing clinical trial management processes and ensuring compliance with regulatory standards.
Previous Experience at Revance Therapeutics
Prior to his current position, Dr. Patki worked at Revance Therapeutics, Inc. as the Senior Director of Clinical Operations from 2019 to 2021. He was responsible for leading clinical operations in Newark, California, and played a key role in the management of clinical trials during his tenure.
Education and Expertise
Dr. Patki earned his Ph.D. in Pharmaceutical Sciences from the University of Mumbai, where he studied from 1988 to 1997. He also holds a bachelor's degree in arts and a master's degree from the Bombay College of Pharmacy. His expertise includes inspection readiness, quality assurance, compliance, process improvements, training, and people management.
Career Background in Clinical Operations
Dr. Patki has over 23 years of experience in global clinical operations within the pharmaceutical and biotechnology sectors. His career includes roles at Allergan Singapore Pte Ltd, Amgen (Asia) Ltd, and Boehringer Ingelheim Singapore Pte Ltd, where he held various leadership positions focused on clinical operations and study management.
Specialization in Clinical Operations
Dr. Patki specializes in clinical operations, particularly in areas such as study management and Clinical Research Associate (CRA) management. His extensive background in clinical trial management and operational leadership has equipped him with the skills necessary to enhance process efficiency and ensure compliance within clinical studies.